Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

37.13USD
18 Jan 2019
Change (% chg)

$1.25 (+3.48%)
Prev Close
$35.88
Open
$36.04
Day's High
$37.45
Day's Low
$36.04
Volume
172,831
Avg. Vol
268,399
52-wk High
$73.90
52-wk Low
$22.23

Chart for

About

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct... (more)

Overall

Beta: --
Market Cap(Mil.): $783.42
Shares Outstanding(Mil.): 40.59
Dividend: --
Yield (%): --

Financials

  CRSP.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.07 -- --
ROI: -16.50 8.99 14.48
ROE: -56.05 10.13 15.99

Earnings vs. Estimates